Search Results

964 articles with title/keywords/abstract containing Pharmaceutical-industry

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
modify search
Display per page 

Content loaded within last 14 days FDA warns about several Genzyme-manufactured products

Source: Reactions, Volume 1, Number 1279, 2009-11-21 , pp. 4-4(1)

Publisher: Adis International

Content loaded within last 14 days Economic analyses of aromatase inhibitors that are sponsored by pharmaceutical companies are less likely to report unfavourable results

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 591, 2009-11-14 , pp. 13-13(1)

Publisher: Adis International

US drug price rollback could hurt pharmacies

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 587, 2009-09-19 , pp. 9-9(1)

Publisher: Adis International

Significant legal issues `cloud' the projected growth of South Korea's pharmaceutical market

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 587, 2009-09-19 , pp. 11-11(1)

Publisher: Adis International

US and European innovation comparisons spark controversy

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 586, 2009-09-05 , pp. 2-2(1)

Publisher: Adis International

Global healthcare faces traumatic transition

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 586, 2009-09-05 , pp. 3-3(1)

Publisher: Adis International

Depression, SLE and diabetes drug markets set for growth

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 586, 2009-09-05 , pp. 10-10(1)

Publisher: Adis International

White House assurances to pharma cause anger

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 585, 2009-08-22 , pp. 2-2(1)

Publisher: Adis International

Philippines: essential drug prices to halve

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 583, 2009-07-25 , pp. 10-10(1)

Publisher: Adis International

Intellectual property rights helping limit drug accessibility

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 581, 2009-06-27 , pp. 3-3(1)

Publisher: Adis International

A recent report has predicted that hepatitis C virus (HCV) drug sales will almost quadruple by 2013, across major markets.

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 581, 2009-06-27 , pp. 10-10(1)

Publisher: Adis International

Pharma required to fund Australian government committee

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 579, 2009-05-30 , pp. 9-9(1)

Publisher: Adis International

Etanercept, infliximab and adalimumab have driven the growth in the spondyloarthropathy market, which reached nearly $US2 billion

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 579, 2009-05-30 , pp. 14-14(1)

Publisher: Adis International

The Chinese non-small-cell lung cancer (NSCLC) drug market is expected to more than double by 2013

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 579, 2009-05-30 , pp. 15-15(1)

Publisher: Adis International

The market for innovative biotherapies for cancer is expected to have strong growth over the next 10 years

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 579, 2009-05-30 , pp. 15-15(1)

Publisher: Adis International

The growth of drug sales of the top ten pharmaceutical companies slowed in 2008

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 579, 2009-05-30 , pp. 15-15(1)

Publisher: Adis International

Opinions divided over new UK flexible drug-pricing scheme

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 577, 2009-05-02 , pp. 2-2(1)

Publisher: Adis International

Generics vs brand name drug pricing: pros and cons debated

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 577, 2009-05-02 , pp. 10-10(1)

Publisher: Adis International

The value of the global pharmaceutical market is predicted to grow by only 2.5%−3.5% on a constant dollar basis in 2009

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 577, 2009-05-02 , pp. 10-10(1)

Publisher: Adis International

The small cell lung cancer (SCLC) drug market is predicted to double by 2017, despite "disappointing" drug development in this area

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 576, 2009-04-18 , pp. 15-15(1)

Publisher: Adis International

modify search
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A